| New 6-amino-pyrido [2, 3-d] pyrimidine-2, 4-diones as novel agents to treat type 2 diabetes: a simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and … M Adib, F Peytam, M Rahmanian-Jazi, S Mahernia, HR Bijanzadeh, ... European Journal of Medicinal Chemistry 155, 353-363, 2018 | 82 | 2018 |
| Design, synthesis and in vitro α-glucosidase inhibition of novel coumarin-pyridines as potent antidiabetic agents M Adib, F Peytam, M Rahmanian-Jazi, M Mohammadi-Khanaposhtani, ... New Journal of Chemistry 42 (21), 17268-17278, 2018 | 55 | 2018 |
| An efficient and targeted synthetic approach towards new highly substituted 6-amino-pyrazolo[1,5-a]pyrimidines with α-glucosidase inhibitory activity F Peytam, M Adib, R Shourgeshty, L Firoozpour, M Rahmanian-Jazi, ... Scientific Reports 10 (1), 2595, 2020 | 31 | 2020 |
| Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and in silico studies M Adib, F Peytam, R Shourgeshty, M Mohammadi-Khanaposhtani, ... Bioorganic & medicinal chemistry letters 29 (5), 713-718, 2019 | 31 | 2019 |
| Design and synthesis of new imidazo [1, 2-b] pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies F Peytam, M Adib, R Shourgeshty, M Mohammadi-Khanaposhtani, ... Molecular diversity 24, 69-80, 2020 | 30 | 2020 |
| Isoindolin-1-one derivatives as urease inhibitors: Design, synthesis, biological evaluation, molecular docking and in-silico ADME evaluation F Peytam, M Adib, S Mahernia, M Rahmanian-Jazi, M Jahani, B Masoudi, ... Bioorganic chemistry 87, 1-11, 2019 | 29 | 2019 |
| Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2, 4-diarylbenzo [4, 5] imidazo [1, 2-a] pyrimidines against yeast and … F Peytam, G Takalloobanafshi, T Saadattalab, M Norouzbahari, ... Scientific reports 11 (1), 11911, 2021 | 27 | 2021 |
| A one-pot, three-component and solvent-free synthesis of 2, 3-disubstituted isoindolin-1-ones M Adib, F Peytam, M Zainali, LG Zhu, J Wu Tetrahedron letters 56 (33), 4729-4732, 2015 | 22 | 2015 |
| A new synthetic strategy towards 2, 4, 5-trisubstituted 1H-imidazoles and highly substituted pyrrolo [1, 2-c] imidazoles by use of α-azidochalcones via Michael addition … M Adib, F Peytam, M Rahmanian-Jazi, HR Bijanzadeh, M Amanlou Tetrahedron 73 (48), 6696-6705, 2017 | 17 | 2017 |
| An efficient synthesis of fully substituted pyrazolo [3, 4-b] pyridin-5-amines from α-azidochalcones M Adib, F Peytam Tetrahedron 74 (20), 2414-2420, 2018 | 15 | 2018 |
| Synthesis and biological evaluation of new dihydroindolizino [8, 7-b] indole derivatives as novel α-glucosidase inhibitors F Peytam, M Adib, R Shourgeshty, M Mohammadi-Khanaposhtani, ... Journal of Molecular Structure 1224, 129290, 2021 | 10 | 2021 |
| Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents: A contemporary perspective of SAR and molecular docking studies M Moradi, A Mousavi, Z Emamgholipour, J Giovannini, S Moghimi, ... European Journal of Medicinal Chemistry, 115626, 2023 | 9 | 2023 |
| The possible effect of microRNA-155 (miR-155) and BACE1 inhibitors in the memory of patients with down syndrome and Alzheimer's disease: Design, synthesis, virtual screening … S Mahernia, M Hassanzadeh, M Adib, F Peytam, Z Haghighijoo, A Iraji, ... Journal of Biomolecular Structure and Dynamics 40 (13), 5803-5814, 2022 | 9 | 2022 |
| Mono-and bis-pyrazolophthalazines: Design, synthesis, cytotoxic activity, DNA/HSA binding and molecular docking studies M Hamidinasab, A Ameri, A Hekmat, H Forootanfar, T Mortezazadeh, ... Bioorganic & Medicinal Chemistry 30, 115944, 2021 | 8 | 2021 |
| Structure-based pharmacophore design and virtual screening for novel potential inhibitors of epidermal growth factor receptor as an approach to breast cancer chemotherapy MAMA Shabnam Mahernia, Malihe Hassanzadeh, Niusha Sharifi, Bita Mehravi ... Molecular Diversity 22, 173-181, 2017 | 6* | 2017 |
| Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents M Adib, F Peytam, R Shourgeshty, M Mohammadi-Khanaposhtani, ... vitro, 0 | 6 | |
| Imidazo [1, 2-a] quinazolines as novel, potent EGFR-TK inhibitors: Design, synthesis, bioactivity evaluation, and in silico studies Z Hasanvand, TO Bakhshaiesh, F Peytam, L Firoozpour, E Hosseinzadeh, ... Bioorganic Chemistry 133, 106383, 2023 | 5 | 2023 |
| A one-pot and three-component synthetic approach for the preparation of asymmetric and multi-substituted 1, 4-dihydropyrazines F Peytam, M Adib, R Shourgeshty, M Rahmanian-Jazi, M Jahani, ... Tetrahedron letters 60 (47), 151257, 2019 | 5 | 2019 |
| Imidazopyridine-based kinase inhibitors as potential anticancer agents: A review F Peytam, Z Emamgholipour, A Mousavi, M Moradi, R Foroumadi, ... Bioorganic Chemistry, 106831, 2023 | 3 | 2023 |
| Imidazo[1,2-c]quinazolines as a novel and potent scaffold of α-glucosidase inhibitors: design, synthesis, biological evaluations, and in silico studies F Peytam, F Hosseini, M Hekmati, B Bayati, MS Moghadam, ... Scientific Reports 13 (1), 15672, 2023 | 1 | 2023 |
